Atlas Trials

A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.

Clinical trial NCT06363773 · RECRUITING

Trial details

NCT number
NCT06363773
Sponsor
Elsan
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Cancer
Start date
2026-01-27
Primary completion
2027-04-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.